Naomi Winny Tioline, et al. “Effectiveness of Nivolumab and Pembrolizumab As PD-1 Inhibitors in Unresectable or Metastatic Advanced Melanoma: A Systematic Review”. KESANS : International Journal of Health and Science, vol. 5, no. 10, July 2026, pp. 2027-38, doi:10.54543/kesans.v5i10.692.